Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Cancer's heterogeneity and uncontrolled cell growth make it a leading cause of death.
• Multidrug resistance (MDR) significantly challenges conventional cancer chemotherapy.
• Nanotechnology provides innovative solutions for site-specific drug delivery and overcoming treatment resistance.

Purpose of the Study:

• To review advancements in cancer nanomedicine design and surface engineering.
• To discuss strategies for improving chemotherapy efficacy in MDR cancers.
• To address the challenges of nanomedicine toxicity and the potential of theranostics.

Main Methods:

• Surface engineering of nanomedicines with targeting ligands.
• Utilizing biocompatible materials (polymers, lipids, inorganic) for nanocarrier fabrication.
• Development of nanomedicines for simultaneous therapeutic and diagnostic agent delivery (theranostics).

Main Results:

• Surface-modified nanomedicines demonstrate enhanced drug delivery and efficacy in MDR cancer models.
• Tunable size and surface properties allow for multiple payloads and multivalent targeting.
• Theranostic approaches show promise for real-time therapy monitoring.

Conclusions:

• Rational design and surface engineering of nanomedicines are crucial for effective cancer treatment.
• Nanomedicine holds significant potential to overcome MDR and improve patient outcomes.
• Further research is needed to address the toxicity of advanced nanomaterials in cancer therapy.